Among these, IL-1β as well as IL-6 emerged as particularly significant markers, especially in long COVID-19 patients, pointing towards their key role in driving persistent inflammation and ongoing symptoms following the acute phase of infection [73]. This evidence concerns the gene IL6 and COVID-19.